Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Latest filing published 14 May 2026 for Rocket Pharmaceuticals, INC., €2,632. Read the official filing
Filing timeline
BuySaleJohn Militello
Insider track record
Disclosed buys
0
Disclosed sells
27
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John Militello: trading record in brief
John Militello appears in our data through filings on Rocket Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 February 2022 to 13 May 2026, the count stands at 40 filings.
Every open-market trade on record is a sale: 27 sales worth €474k. The rest of the record consists of 3 share grants and 9 option exercises. Since January 2026: no purchases and 3 sales on the market.
The record was last updated on 14 May 2026 with an open-market sale (€2,632) in Rocket Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Militello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
855 shares@ US$3.6060.0007% mcap50.0% of flowCommon StockSEC:0001140361-26-021305:0
1,157 shares@ US$3.3380.6% of flowCommon StockSEC:0001140361-26-006330:0
3,726 shares@ US$3.3121.8% of flowCommon StockSEC:0001140361-26-006045:0
29,982 shares0Common StockSEC:0001140361-26-005411:0
1,086 shares@ US$2.9830.5% of flowCommon StockSEC:0001140361-25-042857:0
19,841 shares@ US$3.9611.8% of flowCommon StockSEC:0001140361-25-038302:0
40,000 shares0Common StockSEC:0001140361-25-034431:0
699 shares@ US$3.0650.4% of flowCommon StockSEC:0001140361-25-032092:0
7,043 shares@ US$3.0193.6% of flowCommon StockSEC:0001140361-25-031761:0
357 shares@ US$6.4460.4% of flowCommon StockSEC:0001140361-25-020163:0
655 shares@ US$6.5280.8% of flowCommon StockSEC:0001140361-25-019902:0
718 shares@ US$7.1580.9% of flowCommon StockSEC:0001140361-25-015426:0
2,737 shares@ US$10.585.7% of flowCommon StockSEC:0001140361-25-005845:0
20,080 shares0Common StockSEC:0001140361-25-004292:0
896 shares@ US$10.381.8% of flowCommon StockSEC:0001140361-25-002069:0
1,224 shares@ US$13.0543.1% of flowCommon StockSEC:0001140361-24-047757:0
917 shares@ US$16.6252.9% of flowCommon StockSEC:0001140361-24-045099:0
1,064 shares@ US$18.5043.7% of flowCommon StockSEC:0001140361-24-037934:0
812 shares@ US$23.0153.5% of flowCommon StockSEC:0001140361-24-034029:0
1,079 shares@ US$23.354.8% of flowCommon StockSEC:0001140361-24-026881:0
833 shares@ US$22.873.7% of flowCommon StockSEC:0001140361-24-021703:0
2,903 shares0Common StockSEC:0001140361-24-015101:0
10,000 shares@ US$12.5523.7% of flowCommon StockSEC:0001140361-24-011170:0
3,238 shares@ US$29.83818.4% of flowCommon StockSEC:0001140361-24-008888:0
6,274 shares0Common StockSEC:0001140361-24-008357:0
25 of 40 declarations
